The annual congress of the European Society for Medical Oncology (ESMO), Europe's largest cancer society, has been underway in Madrid, Spain, since Friday.

As Korean visitors walk through the halls filled with promotional booths for pharmaceutical companies worldwide, they notice a familiar name among the global pharma: Elevar Therapeutics, the U.S. subsidiary of HLB.

Please refer to the following website for further details : https://www.koreabiomed.com/news/articleView.html?idxno=22313